Literature DB >> 10590893

Chemotherapeutic neuropathy.

A J Windebank1.   

Abstract

Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590893     DOI: 10.1097/00019052-199910000-00010

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  25 in total

1.  Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.

Authors:  Floortje Mols; Antoinetta J M Beijers; Gerard Vreugdenhil; Anna Verhulst; Goof Schep; Olga Husson
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

2.  A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.

Authors:  Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiridon Papapetropoulos; Panagiotis Polychronopoulos; Haralabos P Kalofonos
Journal:  Support Care Cancer       Date:  2006-04-19       Impact factor: 3.603

3.  Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies.

Authors:  Andreas A Argyriou; Panagiotis Polychronopoulos; Gregoris Iconomou; Angelos Koutras; Haralabos P Kalofonos; Elisabeth Chroni
Journal:  J Neurol       Date:  2005-11-15       Impact factor: 4.849

4.  Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor.

Authors:  Chien-Ming Li; Zhao Wang; Yan Lu; Sunjoo Ahn; Ramesh Narayanan; Jeffrey D Kearbey; Deanna N Parke; Wei Li; Duane D Miller; James T Dalton
Journal:  Cancer Res       Date:  2010-11-16       Impact factor: 12.701

5.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

Authors:  Lauren E Ta; Allan J Bieber; Susan M Carlton; Charles L Loprinzi; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

6.  Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.

Authors:  Virginia Ip; Johnson J Liu; Julian F B Mercer; Mark J McKeage
Journal:  Mol Pain       Date:  2010-09-13       Impact factor: 3.395

7.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

8.  Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic Anti-Neoplastic Potency of Epirubicin-(C3-amide)-Anti-HER2/neu Synthesized Utilizing a UV-Photoactivated Anthracycline Intermediate.

Authors:  C P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Clin Oncol       Date:  2012-11

9.  Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.

Authors:  R L Oostendorp; P O Witteveen; B Schwartz; L D Vainchtein; M Schot; A Nol; H Rosing; J H Beijnen; E E Voest; J H M Schellens
Journal:  Invest New Drugs       Date:  2009-04-30       Impact factor: 3.850

10.  Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity.

Authors:  Sonia Arora; Xin I Wang; Susan M Keenan; Christina Andaya; Qiang Zhang; Youyi Peng; William J Welsh
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.